222 related articles for article (PubMed ID: 10235371)
41. Plasma HIV-1 RNA and route of transmission in oral candidiasis and oral hairy leukoplakia.
Margiotta V; Campisi G; Mancuso S
Oral Dis; 2000 May; 6(3):194-5. PubMed ID: 10822365
[No Abstract] [Full Text] [Related]
42. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART.
Gaitán-Cepeda LA; Martínez-González M; Ceballos-Salobreña A
AIDS Patient Care STDS; 2005 Feb; 19(2):70-7. PubMed ID: 15716638
[TBL] [Abstract][Full Text] [Related]
43. HIV-associated oral lesions: prevalence in Zambia.
Hodgson TA
Oral Dis; 1997 May; 3 Suppl 1():S46-50. PubMed ID: 9456656
[TBL] [Abstract][Full Text] [Related]
44. HIV-related oral manifestations among adolescents in a multicenter cohort study.
Shiboski CH; Wilson CM; Greenspan D; Hilton J; Greenspan JS; Moscicki AB;
J Adolesc Health; 2001 Sep; 29(3 Suppl):109-14. PubMed ID: 11530311
[TBL] [Abstract][Full Text] [Related]
45. Association of HIV viral load with oral diseases.
Baqui A; Meiller T; Jabra-Rizk M; Zhang M; Kelley J; Falkler W
Oral Dis; 1999 Oct; 5(4):294-8. PubMed ID: 10561716
[TBL] [Abstract][Full Text] [Related]
46. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
[TBL] [Abstract][Full Text] [Related]
47. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
48. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy.
Patton LL; McKaig R; Strauss R; Rogers D; Eron JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Mar; 89(3):299-304. PubMed ID: 10710453
[TBL] [Abstract][Full Text] [Related]
49. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions.
Lamster IB; Begg MD; Mitchell-Lewis D; Fine JB; Grbic JT; Todak GG; el-Sadr W; Gorman JM; Zambon JJ; Phelan JA
Oral Surg Oral Med Oral Pathol; 1994 Aug; 78(2):163-74. PubMed ID: 7936584
[TBL] [Abstract][Full Text] [Related]
50. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research.
Rompalo AM; Astemborski J; Schoenbaum E; Schuman P; Carpenter C; Holmberg SD; Warren DL; Farzadegan H; Vlahov D; Smith DK
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):448-54. PubMed ID: 10225226
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of HIV-associated oral lesions and their relation to therapy.
Birnbaum W; Hodgson TA; Reichart PA; Sherson W; Nittayananta W; Axell TE
Oral Dis; 2002; 8 Suppl 2():110-4. PubMed ID: 12164643
[TBL] [Abstract][Full Text] [Related]
52. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.
Palumbo PE; Raskino C; Fiscus S; Pahwa S; Fowler MG; Spector SA; Englund JA; Baker CJ
JAMA; 1998 Mar; 279(10):756-61. PubMed ID: 9508151
[TBL] [Abstract][Full Text] [Related]
53. DMFT index and oral mucosal lesions associated with HIV infection: cross-sectional study in Porto Velho, Amazonian region - Brazil.
Aleixo RQ; Scherma AP; Guimarães G; Cortelli JR; Cortelli SC
Braz J Infect Dis; 2010; 14(5):449-56. PubMed ID: 21221472
[TBL] [Abstract][Full Text] [Related]
54. Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil.
da Silva CA; Dourado I; Dahia SR; Harzheim E; Rutherford GW
J Public Health Dent; 2008; 68(3):178-81. PubMed ID: 18248345
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand.
Sivayathorn A; Srihra B; Leesanguankul W
Ann Acad Med Singap; 1995 Jul; 24(4):528-33. PubMed ID: 8849182
[TBL] [Abstract][Full Text] [Related]
56. Epidemiology of HIV-related oral manifestations in women: a review.
Shiboski CH
Oral Dis; 1997 May; 3 Suppl 1():S18-27. PubMed ID: 9456651
[TBL] [Abstract][Full Text] [Related]
57. Oral manifestations related to immunosuppression degree in HIV-positive children.
Santos LC; Castro GF; de Souza IP; Oliveira RH
Braz Dent J; 2001; 12(2):135-8. PubMed ID: 11450684
[TBL] [Abstract][Full Text] [Related]
58. Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.
Bratt G; Karlsson A; Leandersson AC; Albert J; Wahren B; Sandström E
AIDS; 1998 Nov; 12(16):2193-202. PubMed ID: 9833861
[TBL] [Abstract][Full Text] [Related]
59. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients.
Ammatuna P; Campisi G; Giovannelli L; Giambelluca D; Alaimo C; Mancuso S; Margiotta V
Oral Dis; 2001 Jan; 7(1):34-40. PubMed ID: 11354920
[TBL] [Abstract][Full Text] [Related]
60. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
